Is TCF7L2 useful for longevity?

TCF7L2 is a well-studied gene whose variants (e.g., rs7903146) are strongly associated with increased risk of type 2 diabetes. Diabetes is a risk factor for reduced lifespan, so TCF7L2 could indirectly affect longevity. However, direct evidence for a role in longevity is weak – no robust studies link TCF7L2 variants to extended lifespan. The effects on glucose metabolism are moderate and heavily modulated by lifestyle factors (diet, exercise). A genetic test for TCF7L2 can provide information on diabetes risk, but not on longevity per se. For comprehensive longevity assessment, biomarkers like HbA1c, fasting glucose, and insulin are more actionable. Caveat: The clinical utility of TCF7L2 testing for prevention is limited because effect sizes are small and lifestyle interventions have the greatest impact. Evidence: human-strong for diabetes, but only indirect for longevity.